| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.36T | 4.76T | 4.51T | 3.97T | 2.30T | 1.37T |
| Gross Profit | 1.76T | 2.17T | 1.66T | 1.38T | 1.14T | 1.14T |
| EBITDA | 532.95B | 608.09B | 533.62B | 335.19B | 210.90B | 286.15B |
| Net Income | 370.05B | 362.13B | 340.74B | 165.86B | 92.79B | 143.00B |
Balance Sheet | ||||||
| Total Assets | 60.37T | 62.65T | 56.80T | 55.15T | 47.77T | 43.41T |
| Cash, Cash Equivalents and Short-Term Investments | 34.65T | 5.01T | 5.51T | 5.15T | 4.52T | 3.64T |
| Total Debt | 31.79T | 17.30T | 31.35T | 30.96T | 26.15T | 23.48T |
| Total Liabilities | 56.76T | 58.79T | 53.22T | 51.70T | 44.55T | 40.44T |
| Stockholders Equity | 3.49T | 3.71T | 3.47T | 3.35T | 3.15T | 2.91T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.20T | -868.58B | -13.14B | -865.99B | -974.16B |
| Operating Cash Flow | 0.00 | -842.96B | -678.61B | 132.64B | -694.82B | -862.83B |
| Investing Cash Flow | 0.00 | -1.50T | -848.65B | -887.94B | -233.22B | -593.18B |
| Financing Cash Flow | 0.00 | 2.10T | 1.68T | 1.01T | 1.28T | 1.11T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $30.24B | 13.93 | 23.00% | 1.26% | 5.84% | 1.44% | |
71 Outperform | $297.41B | 11.46 | 16.66% | 2.14% | 16.38% | 29.43% | |
71 Outperform | $153.82B | 16.55 | 19.09% | 1.07% | 8.11% | 53.31% | |
70 Outperform | $273.43B | 11.41 | 14.57% | 1.55% | -1.70% | 26.98% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
60 Neutral | $25.70B | 32.56 | 18.57% | 0.32% | 37.18% | -21.84% | |
59 Neutral | $23.69B | 10.17 | 10.23% | 4.76% | -3.00% | 12.78% |